A Day Up For 4D Molecular Therapeutics Inc.
Tue, Nov 15, 2022 at 07:29 PM
4D Molecular Therapeutics Inc. (FDMT:NASDAQ) soared at $18.69, a gain of 38.5%. On Tue, Nov 15, 2022, FDMT:NASDAQ touched a New 2-Week High of $18.69. The stock appeared on our News Catalysts scanner on Mon, Nov 14, 2022 at 05:37 PM in the 'BIOTECH' category. From Tue, Nov 01, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
About 4D Molecular Therapeutics Inc. (FDMT:NASDAQ)
4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors.
Top 10 Gainers:
- SatixFy Communications Ltd. (SATX:NYSEMKT), 140.73%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 45.74%
- Exagen Inc. (XGN:NASDAQ), 42.38%
- Gelesis Holdings Inc. (GLS:NYSE), 40.03%
- 4D Molecular Therapeutics Inc. (FDMT:NASDAQ), 38.55%
- HUYA Inc. (HUYA:NYSE), 38.26%
- WiMi Hologram Cloud Inc. (WIMI:NASDAQ), 37.32%
- Sea Limited (SE:NYSE), 36.05%
- SenesTech, Inc. (SNES:NASDAQ), 35.82%
- Perfect Corp. Class A (PERF:NYSE), 33.2%